Cargando…
COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
Clozapine, an antipsychotic, is associated with increased susceptibility to infection with COVID-19, compared to other antipsychotics. Here, we investigate associations between clozapine treatment and increased risk of adverse outcomes of COVID-19, namely COVID-related hospitalisation, intensive car...
Autores principales: | Govind, Risha, de Freitas, Daniela Fonseca, Pritchard, Megan, Khondoker, Mizanur, Teo, James T., Stewart, Robert, Hayes, Richard D., MacCabe, James H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784620/ https://www.ncbi.nlm.nih.gov/pubmed/35152033 http://dx.doi.org/10.1016/j.euroneuro.2022.01.007 |
Ejemplares similares
-
Clozapine treatment and risk of COVID-19 infection: retrospective cohort study
por: Govind, Risha, et al.
Publicado: (2021) -
Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records
por: de Freitas, Daniela Fonseca, et al.
Publicado: (2022) -
Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020) -
41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018) -
Ethnic inequalities in treatment with clozapine
por: Fonseca De Freitas, D., et al.
Publicado: (2022)